News Sentiment

PACB sentiment intelligence

Pacific Biosciences of California news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report Factors RSS feed
Weighted score 55 Balanced news tone 47 relevant articles
Exchange NASDAQ United States
Sector Healthcare Market context
Industry Medical Devices Read-through group
Latest close 1.56 Week of 10 Jul 2026
Weighted tone 55/100

Balanced news tone

Market reaction Price moving ahead of tone

Price is moving more forcefully than the current news tone suggests.

Primary event Earnings

78/100 classification confidence.

Company focus 36

directly relevant articles

Source quality 0

high-authority source matches

Trend context Trend inactive

-7.1% over one week, +19.1% over four weeks, trend inactive, and below fair value.

Latest direct headline Neutral

PacBio to Report Second Quarter 2026 Financial Results on August 5, 2026

Market Reaction

Price moving ahead of tone

63/100 confidence

Price is moving more forcefully than the current news tone suggests.

Primary event Earnings 78/100 classification
One-week reaction -7.1% Price reacting lower
Trend fit Trend inactive 19.1% over four weeks
Fair value -51.1% Below fair value
Value support

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 14
Neutral 28
Negative 5

Relevance

Why the article matched

Direct first
Direct company coverage 36
Industry context 11
Sector context 0

Sources

Coverage mix

Publishers
Market source 20
TradingView 8
www.marketscreener.com 4
Quartr 4
Stock Titan 2
Investing.com 2
StockStory 2
MarketBeat 1

Event Lens

What the news is about

Classified themes
Earnings 25
Market update 20
Analyst action 2

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 31-47 of 47